In vitro and in vivo consideration of novel environmentally responsive ophthalmic drug delivery system

References

• Olejnik O. Conventional systems in ophthalmic drug delivery. In: Mitra AK ( ed). Ophthalmic Drug Delivery Systems. New York: Marcel Dekker, Inc; 1993. pp 177–198.
   Google Scholar
• Yusuf A, Kari L. Industrial perspective in ocular drug delivery. Adv Drug Del Rev 2006;58:1258–1268.
   PubMed Web of Science ®Google Scholar
• Chrystele LB, Liliane A, Hosein Z, Pierre AS, Thomas N, Roger L. Ophthalmic drug delivery systems recent advances. Prog Ret Eye Res 1998;17:33–58.
   Google Scholar
• Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug delivery. Adv Drug Del Rev 1995;16:45–50.
   Web of Science ®Google Scholar
• Cohen S, Lobel E, Trevgoda A, Peled Y. A novel in-situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J Control Release 1997;44:201–208.
   Web of Science ®Google Scholar
• Gurny R. Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma. Pharm Acta Helv 1981;56:130–132.
   PubMedGoogle Scholar
• Gurny R, Boye T, Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. J Control Release 1985;2:353–361.
   Google Scholar
• Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 2001;73:205–211.
   PubMed Web of Science ®Google Scholar
• Miller SC, Donovan MD. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharm 1982;12:147–152.
   Web of Science ®Google Scholar
• Desai SD, Blanchard J. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J Pharm Sci 1998;87:226–230.
   PubMed Web of Science ®Google Scholar
• Vadnere M, Amidon G, Lindenbaum S, Haslam JL. Thermodynamic studies on the gel–sol transition of some pluronic polyols. Int J Pharm 1984;22:207–218.
   Web of Science ®Google Scholar
• Spancake CW, Mitra AK, Kildsig DO. Kinetics of aspirin hydrolysis in aqueous solutions and gels of poloxamines (Tetronic 1508) influence of microenvironment. Int J Pharm 1991;75:231–239.
   Web of Science ®Google Scholar
• Rozier A, Manuel C, Groove J, Plazonnet B: Gelrite. A novel, ion-activated, in situ gelling polymer for ophthalmic vehicles: Effect on bioavailability of timolol. Int J Pharm 1989;57:163–168.
   Web of Science ®Google Scholar
• Sanzgiri YD, Maschi S, Crescenzi V, Callegaro L, Topp EM, Stella VJ. Gellan-based systems for ophthalmic sustained delivery of methylprednisolone. J Control Release 1993;26:195–201.
   Web of Science ®Google Scholar
• Zhidong L, Jiawei L, Shufang N, Hui L, Pingtian D, Weisan P. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12–17.
   PubMedGoogle Scholar
• Deshmukh PK, Gattani SG. Design and characterization of a novel environmentally responsive ophthalmic drug delivery system. Eur J Par Pharm Sci 2011;16:87–91.
   Google Scholar
• Hongyi Q, Wenwen C, Chunyan H. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 2007;337:178–187.
   PubMed Web of Science ®Google Scholar
• Deshmukh PK, Fursule RA. Study of a novel environmentally responsive ophthalmic drug delivery system. Int J Pharm Bio Sci 2010;1:1–13.
   Google Scholar
• Davies NM, Farr SJ, Hadgraft J, Kellaway IW. Evaluation of mucoadhesive polymers in ocular drug delivery. I. Viscous solutions. Pharm Res 1991;8:1039–1043.
   PubMed Web of Science ®Google Scholar
• Patton TF, Robinson JR. Ocular evaluation of polyvinyl alcohol vehicle in rabbits. J Pharm Sci 1975;64:1312–1316.
   PubMed Web of Science ®Google Scholar
• Kumar S, Haglund BO, Himmelstein KJ. In situ-forming gels for ophthalmic drug delivery. J Ocul Pharmacol 1994;10:47–56.
   PubMedGoogle Scholar
• Kumar S, Himmelstein KJ. Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. J Pharm Sci 1995;84:344–348.
   PubMed Web of Science ®Google Scholar
• Lin HR, Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release 2000;69:379–388.
   PubMed Web of Science ®Google Scholar
• Nanjawade BK, Manvi FV, Manjappa AS. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release 2007;122:119–134.
   PubMed Web of Science ®Google Scholar
• Ravichandran M, Xiaoling L, Bhaskara RJ. Semisolid dosages: ointments, creams, and gels. In: Shayne CG, ( eds). Pharmaceutical Manufacturing Handbook Production and Processes. New Jersey: John Wiley & Sons, Inc.; 2008. pp 267–312.
   Google Scholar
• Mikac U, Sepe A, Kristl J, Baumgartner S. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength. J Control Release 2010;145:247–256.
   PubMed Web of Science ®Google Scholar
• Wen-Di M, Hui X, Chao W. Pluronic F127-g-poly (acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. Int J Pharm 2008;350:247–256.
   PubMed Web of Science ®Google Scholar